This session will focus on characterizing the current issues surrounding shortages of medically necessary drug products. Speakers will focus on history, repetitive patterns of problems, and our path forward. This will include present initiatives underway and strategies under consideration for effectively dealing with, and mitigating existing drug shortage situations, and for preventing new drug shortages from developing. The respective roles of both industry and the FDA in addressing drug shortage situations will be discussed.

Learning Objectives:
Describe the issues surrounding shortages of medically necessary drug products
Discuss the history, repetitive patterns of problems, and our path forward in dealing with drug shortages.